About Denali Therapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.

Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
161 Oyster Point Blvd, South San Francisco, California 94080, US
description icon
Founded
2015
description icon
Keywords
Biotechnology, Pharmaceuticals, Neurodegeneration, Neurodegenerative Disease

Denali Therapeutics Alternatives

Industry
retail
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Denali Therapeutics

Who is the CEO of Denali Therapeutics?

Ryan Watts is the CEO of Denali Therapeutics. To contact Ryan Watts email at [email protected] or [email protected].

Who are the decision makers in Denali Therapeutics?

The decision makers in Denali Therapeutics are Anthony Delucchi, Cynthia Wong, Don Zhong, etc. Click to Find Denali Therapeutics decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more